Skip to main content
. 2015 Oct 15;18(1):80–86. doi: 10.5853/jos.2015.01298

Table 1.

Baseline characteristics and factors associated with favorable outcome

Total (n=94) Favorable outcome (n=44) Unfavorable outcome (n=50) P
Sex (male) 54 (57.4) 29 (65.9) 25 (50.0) 0.120
Age (year) 68.7 ±10.3 68.0±9.3 69.4±11.1 0.498
Previous cerebrovascular accident 39 (41.5) 18 (40.9) 21 (42.0) 0.915
Diabetes Mellitus 27 (28.7) 13(29.5) 14 (28.0) 0.869
Hypertension 58 (61.7) 21 (47.7) 37 (74.0) 0.009
Hypercholesterolemia 41 (43.6) 19 (43.2) 22 (44.0) 0.936
Smoker 15 (16.0) 8 (18.2) 7 (14.0) 0.581
Atrial fibrillation 46 (48.9) 15 (34.1) 31 (62.0) 0.007
Initial NIHSS 16 (12-20) 13 (11-18) 18 (14-21) 0.001
Occlusion site 0.021
 Internal carotid artery 43 (45.9) 16 (36.4) 27 (55.0)
 Middle cerebral artery M1 34 (36.2) 15 (34.1) 19 (38.0)
 Middle cerebral artery M2 17 (18.1) 13 (29.5) 4 (8.0)
IV tPA 58 (61.2) 30 (68.2) 28 (56.0) 0.225
Intra-arterial therapy (IAT) modality 0.012
 Urokinase 46 (48.9) 19 (43.2) 27 (54.0)
 Penumbra 7 (7.4) 0 (0.0) 7 (14.0)
 Solitaire 36 (38.3) 23 (52.3) 13 (26.0)
 Other 5 (5.3) 2 (4.5) 3 (6.0)
Successful reperfusion* 59 (62.8) 34 (77.3) 25 (50.0) 0.006
Alberta Stroke Program Early CT Score (ASPECTS) 8 (6-9) 9 (7-10) 6 (3-9) <0.001
Gray-matter Volume Estimate Score (GRAVES) 6.2 (2.4-13.8) 3.9 (1.6-6.4) 11.1 (5.0-20.3) <0.001

Data are presented with number (%), mean±standard deviation, or median (interquartile range [IQR]).

*

Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade 2b or 3.

NIHSS, National Institutes of Health Stroke Scale; IV tPA, intravenous tissue plasminogen activator.